default author photo

Youngil Koh

Seoul National University - Department of Internal Medicine

1 Gwanak-ro

Gwanak-gu

Seoul

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

2

DOWNLOADS

180

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Phase I Study of Ex Vivo-Expanded Allogeneic Natural Killer Cells (MG4101) with Rituximab in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Number of pages: 28 Posted: 03 May 2022
University of Ulsan - Asan Medical Center, Seoul National University - Department of Internal Medicine, GC Cell - Cell Therapy Research Center, GC Cell - Cell Therapy Research Center, Korea Advanced Institute of Science and Technology (KAIST) - Graduate School of Medical Science and Engineering, GC Cell - Cell Therapy Research Center and Sungkyunkwan University - Samsung Medical Center
Downloads 126 (580,653)

Abstract:

Loading...

ex vivo-expanded allogeneic natural killer cell, rituximab, relapsed/refractory B-cell non-Hodgkin lymphoma, MG4101

2.

Comprehensive Analysis of Peripheral T-Cell and Natural Killer/T-Cell Lymphoma in Asian Patients: A Multinational, Multicenter, Prospective Registry Study in Asia

Number of pages: 45 Posted: 17 Dec 2020
Sungkyunkwan University - Samsung Medical Center, Peking University - Peking University Cancer Hospital & Institute, Sungkyunkwan University - Division of Hematology-Oncology, University of Ulsan - Department of Oncology, National Cheng Kung University - Division of Hematology and Oncology, Seoul National University - Department of Internal Medicine, Anam Hospital Korea University Medical Center - Department of Internal Medicine, Division of Hematology-Oncology, Kosin University Gospel Hospital, Department of Internal Medicine, Chungnam National University College of Medicine, Chinese Academy of Medical Sciences - National Cancer Center, Department of Haematology-Oncology, National University Health System, University of Indonesia (UI), Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, Keimyung University - Dongsan Medical Center, Department of Hematology-Oncology, Konkuk University Medical Center, Subang Jaya Medical Center, Division of Hemato-Oncology, Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Fudan University Shanghai Cancer Center, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Korea Institute of Radiological and Medical Sciences, Department of Internal Medicine, Chungnam National University College of Medicine, Division of Hematology and Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Raffles Cancer Centre, Division of Hematology–Oncology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonbuk National University, Department of Hematology and Medical Oncology, College of Medicine, Kyung Hee University, Division of Hematology–Oncology, Ewha Womans University Mokdong Hospital, Ewha Womans University, Dong-A University, School of Medicine, Dong-A University Hospital, Department of Internal Medicine, Department of Internal Medicine, Wonkwang University School of Medicine, Chungnam National University, Inje University - Department of Medicine, Department of Internal Medicine, Soonchunhyang University College of Medicine, Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, Ulsan University College of Medicine, Sungkyunkwan University - Samsung Medical Center, Peking University - Key Laboratory of Carcinogenesis and Translational Research and Sungkyunkwan University - Division of Hematology-Oncology
Downloads 54 (1,020,567)

Abstract:

Loading...

Lymphoma, T-Cell, Peripheral; Lymphoma, Extranodal NK-T-Cell; Incidence; Therapeutics; Survival; Prognosis